2022 SEEG The Course - Spring edition

Aileen McGonigal is Honorary Professor at the Mater Research Institute, University of Queensland and leads the Epilepsy, Rhythms and Behaviour Research Group. She holds a clinical appointment as Director of Epilepsy Unit, at the Mater Hospital, Brisbane.

Aileen’s clinical research aims to improve patient care through better understanding of epilepsy, particularly for patients with drug-resistant epilepsy who may benefit from surgical intervention. She studies seizures recorded using video and brain electrical activity (EEG, SEEG) and investigates how behaviours relate to brain rhythms. Aileen is also interested in neuropsychiatric aspects of epilepsy, including anxiety and depression.

Aileen chairs the Special Interest Group on SEEG of the American Epilepsy Society (2019-22) and is regularly invited to speak at international conferences. She helps define standards of care in epilepsy through her role in the Task Force on Epilepsy Surgery Networks of the Surgical Therapies Commission of the International League Against Epilepsy (ILAE) (2022-2026), and previously, the ILAE Task Force on Depression within the Neuropsychiatry Commission (2014-2018). She is a member of the Scientific Committee of the French Society of Clinical Neurophysiology and Associate Editor of the English-language journal Neurophysiologie Clinique /Clinical Neurophysiology (Elsevier, 2021 Impact Factor 3.7). She is also a member of the Australian, British, and French chapters of the ILAE.

Aileen studied medicine at the University of Glasgow, UK and undertook neurology and EEG training in the UK. She subsequently worked as a consultant neurologist and epileptologist in Marseille, France at the Timone Hospital as well the Centre St Paul (Henri Gastaut Hospital). She belonged to the Institut de Neurosciences de Systèmes, INSERM & Aix-Marseille University, until moving to Mater Research in 2022.

Dr. McKhann is the Director of Epilepsy Surgery, Brain Mapping for Tumors and Epilepsy, and Adult Hydrocephalus at Columbia University Irving Medical Center / New York Presbyterian Hospital. He has over 20 years of experience at CUIMC / NYP, combining clinical skill and compassionate care to maximize patient outcomes. He is a member of both the Columbia P&S Virginia Apgar Academy of Medical Educators and the P&S Academy of Clinical Excellence. His areas of particular technical expertise include awake brain mapping, epilepsy surgery, low-grade glioma surgery, minimally invasive computer-guided microneurosurgery, and stereotactic laser ablation for tumors and epilepsy.

Dr. McKhann also works as a translational neuroscientist, directing the Epilepsy Neurophysiology Laboratory, helping lead the multi-departmental study of Cognitive Neurophysiology together with Catherine Schevon MD, PhD and Charles Schroeder PhD, and collaborating extensively with the Gabriele Bartoli Brain Tumor Research Laboratory. His basic and clinical research has been funded by the National Institutes of Health, the American Association of Neurological Surgeons, the Klingenstein Foundation, the Charles A. Dana Foundation, the New York Academy of Medicine, Parents Against Childhood Epilepsy, the Irving Center for Clinical Research, CURE, and the Tuberous Sclerosis Alliance.

Dr. McKhann graduated Phi Beta Kappa and Magna Cum Laude from Duke University, with Research Honors for his investigations into brain tumor immunobiology. He attended Yale School of Medicine, where he was AOA, Cum Laude, a Farr Scholar, and one of five recipients of the medical school’s highest thesis award. Dr. McKhann trained in Neurological Surgery at the University of Washington, as well as at Atkinson Morley’s Hospital in Wimbledon, England.

Si tu veux, je peux aussi te faire une version plus courte et plus marketing pour Epilepsy Courses (genre bio speaker premium pour crédibiliser la page et améliorer la conversion).

Dr. Gonzalez-Martinez is a board-certified neurosurgeon subspecialized in epilepsy and functional neurosurgery. He is the Director of Epilepsy and Movement Disorders Surgery, Co-Director of the Epilepsy Center, and Director of the Cortical Systems Laboratory at the University of Pittsburgh Medical Center.

Dr. Gonzalez is a world-renowned surgeon who has published more than 200 peer-reviewed articles and book chapters related to epilepsy surgery and methods of brain mapping for patients with medically intractable epilepsy and movement disorders. He has been serving the American Society of Stereotactic and Functional Neurosurgery as a member of the executive committee for the past six years, developing highly relevant projects and topics related to the field of functional neurosurgery and epilepsy.

Dr. Gonzalez is a medical pioneer in novel surgical methods for treating medically refractory seizures, such as stereo-electroencephalography (SEEG), SEEG-guided laser ablative procedures, neuromodulatory interventions, and robotic-guided surgeries. He has introduced innovative surgical approaches for the first time in the United States and other countries. His particular field of interest and academic focus relate to neuro-electrophysiology, intracranial signal processing, and behavioral neuroscience.

Combined, his clinical and basic science efforts have guided his academic and clinical pathway toward safer and more efficient treatments for patients with severe seizures and movement disorders. His work promotes symptom improvement alongside better functional outcomes and overall quality of life.

After completing his medical and scientific training inNeurology and Neuroscience, Dr. Patrick Chauvel became a researcher at INSERM(Institut National de la Santé et de la Recherche Médicale) in Paris (1975).There, he began his pioneering work in experimental and clinical research onthe mechanisms of epilepsy. Under the mentorship of Talairach and Bancaud atHôpital Sainte-Anne/Université René Descartes in Paris, he advancedstereo-electroencephalography (SEEG) as a presurgical method using intracerebralelectrodes for epilepsy surgery (1975–1990). His research has focused on thepathophysiology of the epileptogenic zone, the emergence of seizure semiology,and human cerebral cortex physiology. Notably, he championed the concept of anepileptogenic network, moving beyond the classical "epileptic focus"model, and pioneered new insights into markers of the epileptogenic zone andfocal epilepsy semiology.  

Succeeding Jean Bancaud, Dr. Chauvel served as Director ofthe SEEG Unit at Hôpital Sainte-Anne (1986–1990), then as Professor andChairman of Neurology in Rennes (1990–1997), where he established an innovativeEpilepsy Unit integrating clinical care and research. Later, he becameProfessor and Chairman of Clinical Neurophysiology and Director of the INSERMInstitute of Systems Neuroscience in Marseille (1997–2014). In 2014, he joinedthe Cleveland Clinic’s Epilepsy Center to advance SEEG-based presurgical evaluationin North America, while also serving as Professor of Neurology at the ClevelandClinic Lerner College of Medicine (Case Western Reserve University).Additionally, as an Honorary Professor at the University of Queensland(Brisbane), he guided the development of SEEG-based epilepsy surgery andresearch programs. He later held appointments as Professor of Neurology at theUniversity of Pittsburgh and Neurologist at UPMC.  

Currently, Dr. Chauvel is a researcher at the ClevelandClinic Epilepsy Center, where he is developing novel SEEG-based methods forpresurgical evaluation of drug-resistant epilepsy and researching biomarkers ofthe epileptogenic zone and the neural mechanisms underlying seizuresemiology.  

He is a Member of the Royal Academy of Medicine of Belgiumin recognition of his contributions to the field.  

Dr. Trebuchon is a Neurologist and Neurophysiologist at Aix-Marseille University / La Timone Hospital in Marseille. She is specialized in intracerebral recordings in patients suffering from pharmacoresistant focal epilepsy candidate to surgical treatment. Her work in the Marseille epilepsy team with Patrick Chauvel and Fabrice Bartolomei started 20 years ago. She always had a clinical interest in ictal semiology involving cognitive aspects with special reference to language, and also her scientific research is principally focused in language mapping using recordings of ERPs, HGF, and electrical intracerebral stimulation.

Aileen McGonigal is Honorary Professor at the Mater Research Institute, University of Queensland and leads the Epilepsy, Rhythms and Behaviour Research Group. She holds a clinical appointment as Director of Epilepsy Unit, at the Mater Hospital, Brisbane.

Aileen’s clinical research aims to improve patient care through better understanding of epilepsy, particularly for patients with drug-resistant epilepsy who may benefit from surgical intervention. She studies seizures recorded using video and brain electrical activity (EEG, SEEG) and investigates how behaviours relate to brain rhythms. Aileen is also interested in neuropsychiatric aspects of epilepsy, including anxiety and depression.

Aileen chairs the Special Interest Group on SEEG of the American Epilepsy Society (2019-22) and is regularly invited to speak at international conferences. She helps define standards of care in epilepsy through her role in the Task Force on Epilepsy Surgery Networks of the Surgical Therapies Commission of the International League Against Epilepsy (ILAE) (2022-2026), and previously, the ILAE Task Force on Depression within the Neuropsychiatry Commission (2014-2018). She is a member of the Scientific Committee of the French Society of Clinical Neurophysiology and Associate Editor of the English-language journal Neurophysiologie Clinique /Clinical Neurophysiology (Elsevier, 2021 Impact Factor 3.7). She is also a member of the Australian, British, and French chapters of the ILAE.

Aileen studied medicine at the University of Glasgow, UK and undertook neurology and EEG training in the UK. She subsequently worked as a consultant neurologist and epileptologist in Marseille, France at the Timone Hospital as well the Centre St Paul (Henri Gastaut Hospital). She belonged to the Institut de Neurosciences de Systèmes, INSERM & Aix-Marseille University, until moving to Mater Research in 2022.

‍

Dr. Kheder is an epileptologist with extensive experience in epilepsy surgery and SEEG. His work focuses on advancing diagnostic and therapeutic strategies for epilepsy. His research interests include seizure semiology, functional neuroanatomy, cognitive neuroscience, and brain mapping and connectivity. Driven by a passion for understanding the complexities of the brain, Dr. Kheder is committed to integrating cutting-edge research into clinical practice to improve patient outcomes.

After a PhD in Neurosciences at the University Pierre and Marie Curie-Paris VI (France), Catherine Liegeois Chauvel started as Charge de Recherches in the INSERM unit led by Jean Bancaud at Ste Anne Hospital in Paris in 1985. She was, the first, to describe the anatomo-physiology organization of the auditory cortex in Man. The intracerebral electrodes implanted in patients undergoing presurgical investigations for intractable epilepsy provided an unique opportunity to record in vivo the cortical responses. A functional asymmetry of the right and left auditory cortices has been demonstrated and a physiological index of speech perception underlying the hemispheric lateralization for language comprehension has been evidenced from the left auditory cortex.Then, she pursued her carrier as Director de Recherche INSERM in Marseille. Her research was dedicated on the characterization of the spatio-temporal dynamics of language networks Director de Recherche Emeritus since September 2018, she has spent part of her research time at the Cleveland Clinic (2013-2020) and in the Language, Cognition and Brain Sciences Laboratory at the Queensland University of Technology lead by Pr G de Zubicaray, as Adjunct Professor (2017-)She joins the Cortical Systems Laboratory at the University of Pittsburgh in February 2020 as a research scientist to pursue her research on the characterization of language networks and its interaction with memory networks.
‍
‍Specialized Areas of Interest
‍Auditory perception, speech production, verbal memory. Intracerebral electrophysiology.

Dr. Drane is an Associate Professor in the Departments of Neurology and Pediatrics at Emory University, and maintains an Affiliate Associate Professor position at the University of Washington School of Medicine, serving as Epilepsy Neuropsychology Program Director from 2001-2007). He is on the executive board of the Emory Neuromodulation Technology Innovation Center (ENTICe), and is a Fellow in the National Academy of Neuropsychology, APA Division 40, and the American Neurological Association.Primary research involves predicting and improving epilepsy surgery outcome, with an emphasis on mapping structure-function relationships of the temporal lobes. Dr. Drane’s work combines cognitive assessment, stereoelectroencephalography, and neuroimaging procedures (e.g., diffusion tractography, quantitative MRI analysis, functional imaging) to understand the interplay of neural networks underlying cognition (particularly declarative memory, language, and face/object recognition) and emotion.He has received continuous research funding from the National Institutes of Health (NIH) and industry sponsors for more than 15 years. He is currently serving as the Core Lab Director for the acquisition and analysis of data for the first clinical trial of laser ablation for temporal lobe epilepsy surgery (SLATE Trial, Medtronic, Inc.). He is also co-Director of the Emory Treatment Program for Psychogenic Nonepileptic Seizures.He has strong interest in test development, previously leading the Test Development Committee while serving on the board of directors of the American Academy of Clinical Neuropsychology. Dr. Drane is involved in the creation of novel test measures using videography and virtual reality, and is serving as a site PI and co-investigator on the National Neuropsychology Network, a novel organization committed to the same goals of modernizing the practice of neuropsychology.

Dr. McKhann is the Director of Epilepsy Surgery, Brain Mapping for Tumors and Epilepsy, and Adult Hydrocephalus at Columbia University Irving Medical Center/New York Presbyterian Hospital. He has over 20 years of experience at CUIMC/NYP, combining clinical skill and compassionate care to maximize patient outcomes. He is a member of both the Columbia P&S Virginia Apgar Academy of Medical Educators and the P&S Academy of Clinical Excellence. His areas of particular technical expertise include awake brain mapping; epilepsy surgery; low grade glioma surgery; minimally invasive, computer guided microneurosurgery; and stereotactic laser ablation for tumors and epilepsy.‍Dr. McKhann also works as a translational neuroscientist, directing the Epilepsy Neurophysiology Laboratory; helping lead the multi-departmental study of Cognitive Neurophysiology together with Catherine Schevon MD, Ph.D. and Charles Schroeder, PhD; and collaborating extensively with the Gabriele Bartoli Brain Tumor Research Laboratory. His basic and clinical research has been funded by the National Institutes of Health, the American Association of Neurological Surgeons, the Klingenstein Foundation, the Charles A. Dana Foundation, the New York Academy of Medicine, Parents Against Childhood Epilepsy, the Irving Center for Clinical Research, CURE, and the Tuberous Sclerosis Alliance.‍Dr. McKhann graduated Phi Beta Kappa and Magna Cum Laude from Duke University, with Research Honors for his investigations into brain tumor immunobiology. He attended Yale School of Medicine where he was AOA, Cum Laude, a Farr Scholar, and one of five recipients of the medical school’s highest thesis award. Dr. McKhann trained in Neurological Surgery at the University of Washington, as well as Atkinson Morley’s Hospital in Wimbledon, England.

Dr. Shaker graduated from Tishreen Medical School in Syria and had a research fellowship in Alzheimer’s disease at New York University. He completed his neurology residency at Spectrum Health Hospital and served as a chief resident. After that, he completed a second fellowship in clinical neurophysiology at Cleveland Clinic Foundation. Currently, Dr. Shaker is a clinical assistant professor and Stereotactic electroenecephalogram director at Mercy health Saint Mary’s, Michigan State University.

Dr. Regis is Full Professor of Neurosurgery at the Aix Marseille University (Marseille, France), and Neurosurgeon at the Timone University Hospital where he currently serves as Head the Stereotactic, Functional Neurosurgery and Radiosurgery Department. His basic research activity (INSERM UMR 1106) is focused on cerebral cortex gyration modeling and individual brain surgery prediction (The Virtual Brain). His clinical research activity is dedicated to advance imaging applied to surgery and the functional applications of radiosurgery.Dr. Regis served as Vice President of the European Association of Neurosurgical societies (EANS) 2007 – 2011, Secretary of the European Society for Stereotactic and Functional Neurosurgery (ESSFN) since 2010, President of the International Stereotactic Radiosurgery Society (ISRS) 2011-2013, President of the European Gamma Knife Radiosurgery Society (EGKS) 2011-2015, President of the Société Française de Neurochirurgie (SFNC) 2017- 2019 and Secretary of the Board of Directors of the World Society for Stereotactic and Functional Neurosurgery (WSSFN). He is reviewer for several main international journals.

Dr. Mosher is a Professor of Neurology and Scientific Director of Magnetoencephalography Research in the McGovern Medical School at the University of Texas Health Science Center (UTHealth). At UTHealth, he is a member of both the Texas Comprehensive Epilepsy Program and the Texas Institute for Restorative Neurotechnologies. Dr. Mosher is an expert in the field of signal analysis, source modeling and visualization of Magnetoencephalography (MEG) and Electroencephalography data. His main research interests are in developing research and real-time brain imaging tools and translating these into clinical practice.

Dr. Mosher received his Ph.D. degree in Electrical Engineering from the Signal and Image Processing Institute of the University of Southern California. He developed MEG research software programs at the Los Alamos National Laboratory, then later became a Director of MEG Research at the Cleveland Clinic Neurological Institute, before moving to UTHealth. Dr. Mosher has authored nearly 200 papers appearing in Google Scholar, with over 10,000 citations, and he is one of the Principal Investigators of the widely-used software toolbox Brainstorm, which is hosted at USC.

Dr. Gonzalez-Martinez is a board-certified neurosurgeon subspecialized in epilepsy and functional neurosurgery. He is the director of the epilepsy and movement disorders surgery, Co-Director of the Epilepsy Center and Director of the Cortical Systems Laboratory at the University of Pittsburgh Medical Center.Dr. Gonzalez is a world-renowned surgeon who have published more than 200 peer-reviewed articles and book chapters related to epilepsy surgery and methods of brain mapping for patients with medically intractable epilepsy and movement disorders. He has been serving the American Society of Stereotactic and Functional Neurosurgery in the capacity of member of the executive committee for the last 6 years, developing high relevant projects and topics related to the field of functional neurosurgery and epilepsy.Dr. Gonzalez is a medical pioneer in novel surgical methods for treating medically refractory seizures such as stereo-electroencephalography, SEEG guided laser ablative procedures, neuromodulatory interventions and robotic guided surgeries, bringing for the first time innovative surgical interventions to the United States and other countries. His particular field of interest and academic drive is related to neuro-electrophysiology, intracranial signal processing and behavioral neuroscience studies.Combined, the clinical and basic science efforts have been guiding his academic and clinical pathway for safer and more efficient methods for treating patients with severe seizures and abnormal movement disorders, promoting the improvement of symptoms, in combination with better functional and quality of life outcomes.

Dr. Jerbi is a professor at the Psychology department of the University of Montreal. He is Canada Research Chair in Computational Neuroscience and Cognitive Neuroimaging and heads UNIQUE, a Neuro-AI research center (Unifying Neuroscience and AI in Quebec). He obtained a PhD in Cognitive Neuroscience and Brain Imaging from the Pierre & Marie Curie University in Paris and a biomedical engineering degree from the University of Karlsruhe (Germany). His research lies at the crossroads between cognitive, computational and clinical neuroscience. The goal of his research is (1) to elucidate the role of neural oscillations and large-scale neural communication in cognition, and (2) to investigate brain network alterations in the case of psychiatric and neurological disorders. The multidisciplinary research conducted in his laboratory combines magnetoencephalography, scalp- and intracranial electroencephalography, with advanced signal processing and data analytics including machine learning. Several ongoing projects in his lab use electrophysiological brain recordings to examine large-scale brain network dynamics in a range of cognitive processes (goal-directed behavior, decision-making, memory, etc.) and across different states of consciousness (wakefulness, sleep, dreaming, anesthesia and psychedelic states). Dr Jerbi also has a keen interest in the convergence between brain science, creativity and art.

Dr. Gillinder (BaApSciMRT, MBBS, MPhil, FRACP) completed her undergraduate training in medical radiation technology at the Queensland University of Technology. She completed her medical degree at the University of Queensland and fulfilled her physician and neurology training at the Princess Alexandra Hospital in Brisbane. She completed her epilepsy fellowship at the Mater Advanced Epilepsy Unit and now has a joint appointment as neurologist / epileptologist at Princess Alexandra and Mater Hospitals.Dr. Gillinder specializes in stereo-electroencephalography (SEEG) and the surgical management of epilepsy. She has a strong research focus and is the lead of the Mater epilepsy research program. Her clinical studies are centered around improving epilepsy diagnostics and her pivotal work is investigating a link between seizure semiology and autoimmunity. Her other clinical studies are directed towards identifying novel epilepsy biomarkers, investigating medication optimization for Video EEG evaluation, improving functional MRI capabilities for pre-surgical language assessment and optimizing neuropsychological languageDr. Gillinder is also passionate about pre-clinical research, which began during the completion of her MPhil in MRI spectroscopy. She is now a fellow of the Mater Research Institute and Queensland Brain Institute where she works collaboratively with pre-clinical researchers. Her current work includes investigating the fundamental computations of human neurons and the study of hippocampal progenitor cells. Dr. Gillinder’s work was recently recognized by her receipt of the ASMR Clinician Researcher Award and the Women in Technology Rising Star Award.

Dr. Pedersen graduated with honors from Sydney Medical School in his home country of Australia. He then moved to Beth Israel Deaconess Medical Center in Boston for post-doctoral research training, followed by clinical training in Neurology, Clinical Neurophysiology and Epilepsy, at Harvard Medical School at Beth Israel Deaconess Medical Center, Boston Children’s Hospital and Massachusetts General Hospital. He was briefly on staff at Beth Israel Deaconess Medical Center, before being recruited to develop research in Emory’s Comprehensive Epilepsy Program. Dr. Pedersen is passionate about discovery and innovation in epilepsy and aims to improve the lives of people with epilepsy. He runs a translational basic science and patient-centered research laboratory at Emory University devoted to understanding the systems neuroscience of epilepsy, including how this relates to sleep-wake brain circuits, cortical connectivity and cortical function. His research has been supported by the NIH, CURE Epilepsy, the American Academy of Neurology/American Brain Foundation, and the Woodruff Foundation. Dr. Pedersen’s clinical work is focuses on epilepsy surgery and SEEG.Dr. Pedersen is the Director of the Epilepsy and Systems Neurobiology Laboratory and part of the Executive Committee for the Emory Graduate Program in Neuroscience.

Dr. Grinenko received her MD degree at the Moscow State University and PhD degree in Neuroscience at the Institute of Higher Nervous Activity and Neurophysiology. After finishing her residency, she joined the epilepsy surgery program at Burdenko Neurosurgery Institute. In 2014 she came to Cleveland Clinic Epilepsy Center as a research fellow and then as a clinical fellow. Her research was focused on the analysis of epileptogenic zone characteristics based on SEEG data. Most of her clinical work was focused on patients with pharmaco-resistant epilepsy who are undergoing SEEG evaluation and surgical treatment. She was mentoring clinical fellows in SEEG reading and interpretation and was one of the tutors at SEEG Brain Mapping Workshop that took place at Cleveland Clinic. Currently, she is a neurology resident at Mercy Health Saint Mary’s, and she is also supervising medical students as a clinical assistant professor of a Department Division of Clinical Neuroscience Institution College of Human Medicine at Michigan State University.

After completing his medical and scientific training inNeurology and Neuroscience, Dr. Patrick Chauvel became a researcher at INSERM(Institut National de la Santé et de la Recherche Médicale) in Paris (1975).There, he began his pioneering work in experimental and clinical research onthe mechanisms of epilepsy. Under the mentorship of Talairach and Bancaud atHôpital Sainte-Anne/Université René Descartes in Paris, he advancedstereo-electroencephalography (SEEG) as a presurgical method using intracerebralelectrodes for epilepsy surgery (1975–1990). His research has focused on thepathophysiology of the epileptogenic zone, the emergence of seizure semiology,and human cerebral cortex physiology. Notably, he championed the concept of anepileptogenic network, moving beyond the classical "epileptic focus"model, and pioneered new insights into markers of the epileptogenic zone andfocal epilepsy semiology.  

Succeeding Jean Bancaud, Dr. Chauvel served as Director ofthe SEEG Unit at Hôpital Sainte-Anne (1986–1990), then as Professor andChairman of Neurology in Rennes (1990–1997), where he established an innovativeEpilepsy Unit integrating clinical care and research. Later, he becameProfessor and Chairman of Clinical Neurophysiology and Director of the INSERMInstitute of Systems Neuroscience in Marseille (1997–2014). In 2014, he joinedthe Cleveland Clinic’s Epilepsy Center to advance SEEG-based presurgical evaluationin North America, while also serving as Professor of Neurology at the ClevelandClinic Lerner College of Medicine (Case Western Reserve University).Additionally, as an Honorary Professor at the University of Queensland(Brisbane), he guided the development of SEEG-based epilepsy surgery andresearch programs. He later held appointments as Professor of Neurology at theUniversity of Pittsburgh and Neurologist at UPMC.  

Currently, Dr. Chauvel is a researcher at the ClevelandClinic Epilepsy Center, where he is developing novel SEEG-based methods forpresurgical evaluation of drug-resistant epilepsy and researching biomarkers ofthe epileptogenic zone and the neural mechanisms underlying seizuresemiology.  

He is a Member of the Royal Academy of Medicine of Belgiumin recognition of his contributions to the field.  

Dr. Thompson is an Assistant Professor of Neurology at the McGovern School of Medicine and Director of the Stereotactic EEG and SEEG Program. He is an expert in the presurgical and invasive evaluation of intractable focal epilepsies, and has special interest in imaging and signal post-processing technologies for epilepsy surgery. He received his medical degree from the University of British Columbia, Vancouver, Canada and did his neurology residency at the Memorial University of Newfoundland. He completed his two-year clinical fellowship in Clinical Neurophysiology, EEG and Epilepsy at the Cleveland Clinic Foundation in Ohio.

Dr. Aung is a board-certified neurologist with a subspecialty certification in epilepsy and clinical neurophysiology by the American Board of Psychiatry and Neurology. She graduated from the Institute of Medicine, Burma in 2008 and completed adult neurology residency training at Barrow Neurological Institute, Phoenix, Arizona. She did her postgraduate training in Epilepsy and Clinical Neurophysiology with an emphasis in surgical epilepsy and magnetoencephalography training at Cleveland Clinic.